GE HealthCare Reports Strong Q1 Performance

GE HealthCare Technologies Inc. announced a notable 3% year-on-year revenue increase to $4.8 billion in the first quarter of fiscal 2025, exceeding market expectations. This growth underscores the company's robust operational execution and strategic initiatives.

Financial Highlights

The company's net income saw a significant 50.8% rise compared to the same period in 2024, reaching $564 million. Diluted earnings per share (EPS) also experienced a 51.85% annual increase to $1.23. In a move to return value to shareholders, GE HealthCare unveiled a $1 billion share repurchase program.

Strategic Growth and Future Outlook

CEO Peter Arduini highlighted the company's strong start to the year, driven by robust revenue, orders, and profit growth, particularly in the U.S. The acquisition of Nihon Medi-Physics is poised to enhance global access to next-generation radiopharmaceuticals, aligning with GE HealthCare's precision care and growth acceleration strategies.

Following the announcement, GE HealthCare's stock price increased by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET.